XML 15 R5.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDER'S EQUITY - USD ($)
Preferred Stock
Series C Convertible Preferred Stock
Preferred Stock
Series D Convertible Preferred Stock
Preferred Stock
Series E Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Series D Convertible Preferred Stock
Series E Convertible Preferred Stock
Total
Beginning balance at Dec. 31, 2024 $ 912,830                  
Beginning balance (in shares) at Dec. 31, 2024 4,285                  
Temporary Equity                    
Deemed dividends on preferred stock $ 53,799         $ (53,799)       $ (53,799)
Preferred stock redemptions and conversions $ (822,362)                  
Preferred stock redemptions and conversions (in shares) (715)                  
Preferred stock accretion $ 1,086,984                  
Preferred stock dividends 47,604         (47,604)       (47,604)
Ending balance at Mar. 31, 2025 $ 1,278,855                  
Ending balance (in shares) at Mar. 31, 2025 3,570                  
Beginning balance at Dec. 31, 2024       $ 137 $ 53,027,049 (47,169,206) $ 5,702     5,863,682
Beginning balance (in shares) at Dec. 31, 2024       1,357,165            
Stockholders' Equity                    
Stock based compensation         3,709         3,709
Issuance of common stock for consulting fees       $ 3 104,613         104,616
Issuance of common stock for consulting fees (in shares)       32,650            
Preferred stock accretion         (1,086,984)         (1,086,984)
Preferred stock dividends $ 47,604         (47,604)       (47,604)
Deemed dividends on preferred stock $ 53,799         (53,799)       (53,799)
Net Income (Loss)           385,169       385,169
Balance, Ending at Mar. 31, 2025       $ 140 52,048,387 (46,885,440) 5,702     5,168,789
Balance, Ending (in shares) at Mar. 31, 2025       1,389,815            
Beginning balance at Dec. 31, 2025   $ 507,927 $ 338,774         $ 507,927 $ 338,774  
Beginning balance (in shares) at Dec. 31, 2025   679 11,000         679 0  
Temporary Equity                    
Preferred stock accretion   $ 184,630 $ 1,840,149              
Accrual of preferred stock dividends   8,545 194,839              
Preferred stock dividends   (6,250) (162,756)              
Ending balance at Mar. 31, 2026   $ 694,852 $ 2,211,006         $ 694,852 $ 2,211,006  
Ending balance (in shares) at Mar. 31, 2026   679 11,000         679 11,000  
Beginning balance at Dec. 31, 2025       $ 746 97,242,028 (76,196,995) 5,702     21,051,481
Beginning balance (in shares) at Dec. 31, 2025       7,448,343            
Stockholders' Equity                    
Stock based compensation         76,600         76,600
Issuance of common stock for consulting fees       $ 2 104,452         104,454
Issuance of common stock for consulting fees (in shares)       23,588            
Preferred stock accretion         (2,024,779)         (2,024,779)
Preferred stock dividends   $ (6,250) $ (162,756)              
Accrual of preferred stock dividends   $ 8,545 $ 194,839              
Accrual of preferred stock dividends           (203,384)       (203,384)
Net Income (Loss)           4,254,392       4,254,392
Balance, Ending at Mar. 31, 2026       $ 748 $ 95,398,301 $ (72,145,987) $ 5,702     $ 23,258,764
Balance, Ending (in shares) at Mar. 31, 2026       7,471,931